I. Blydt-Hansen, M. Bech, and S. Jackson, “Emicizumab in Severe Hemophilia A: Clinical and Patient Determinants of Transition Within a Standardized Program”, J Hematol, vol. 14, no. 5, pp. 257–261, Oct. 2025, doi: 10.14740/jh2113.